India, Feb. 4 -- Drug major Pfizer Inc. (PFE), while reporting a profit in its fourth quarter, compared to prior year's loss, on Tuesday reaffirmed its fiscal 2025 outlook.
In pre-market activity on the NYSE, Pfizer shares were trading at $26.85, up 2.5 percent.
For fiscal 2025, the company continues to expect adjusted earnings per share in a range of $2.80 to $3.00.
The Wall Street analysts on average expect the company to report earnings of $2.93 per share. Analysts' estimates typically exclude special items.
Revenues are still projected to be in the range of $61.0 billion to $64.0 billion. The Street is looking for revenues of $63 billion for the year.
Pfizer said it is maintaining full year 2025 outlook, which was provided on Decem...